Search

everythinglearnresearchcommunity

for

Search:↓

Antiandrogen therapy for hidradenitis suppurativa lacks strong evidence and needs more research.

Hormone therapy with estradiol and spironolactone can regrow scalp hair in transgender women by lowering testosterone to female levels.

Trichotillomania, a disorder where people compulsively pull out their own hair, often starts around age 12, is more common in adult females, and can be treated with behavior therapy and medication.

MC-DNA vector-based gene therapy can temporarily treat CBS deficiency in mice.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

An HIV patient's complete hair loss was reversed after switching from lopinavir/ritonavir to nelfinavir.

European dermatologic treatments focus on lifestyle and psychosocial factors, use diverse methods like baths and climate therapy, and emphasize the importance of diet and supplements for skin health.

Transgender and gender-diverse adults on hormone therapy often face drug-hormone interactions, especially with multiple psychotropic medications.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.

Drospirenone is a unique progestin with anti-water retention and potential blood pressure benefits, used in birth control and hormone therapy.

Chlormadinone acetate is a strong, well-tolerated hormone used in birth control and hormone therapy with benefits for menstrual pain and skin conditions.

Low dose cyclical nutrition therapy can consistently and safely improve hair growth and density without needing anti-androgens.

Stem cells could potentially rebuild missing structures in wounds, improving facial skin replacement techniques.

A topical BRAF inhibitor, vemurafenib, can speed up wound healing and promote hair growth, especially in diabetic patients.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

Hair pulling disorder is treated with therapy and medication; hair loss from tension can be reversed if caught early.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Hydroxychloroquine is less effective than betamethasone oral mini pulse therapy for treating alopecia areata.

Atopic dermatitis may have genetic causes and can be treated with pharmacologic methods, glycerin creams, and controlling Staphylococcus aureus colonization.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

Gilles de la Tourette syndrome is treatable, with behavioral therapy as a recommended first option and other treatments available for more severe cases.

Nanotechnology is improving drug delivery and targeting, with promising applications in cancer treatment, gene therapy, and cosmetics, but challenges remain in ensuring precise delivery and safety.

Some people may naturally have beaded lines on their skin that are more visible with certain treatments, and hair loss similar to post-pregnancy can occur after specific diet and therapy.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Male pattern baldness is often genetic and linked to a hormone, with treatments like finasteride and minoxidil being effective for some men.

Gray-scale ultrasound effectively detects erectile tissue fibrosis in young men with erectile dysfunction after using finasteride.

Sex hormones affect reproduction, sexual development, and oral health, and it's important for dental practitioners to understand their effects and interactions.

Oral valganciclovir improved a patient's skin condition caused by immunosuppression.